The global Single-cell omics market is anticipated to grow at a CAGR of 18.2% during the forecast period (2023-2030). Single-cell omics technologies are increasingly used in cancer research to study tumor heterogeneity and identify new therapeutic targets. As cancer incidence continues to rise, the demand for these technologies is expected to increase. Increasing collaborations between academic and industrial partners are accelerating the adoption of single-cell omics technologies in research and development. According to American Cancer Society, around 1,958,310 new cancer cases as well as 609,820 cancer deaths are estimated to occur in the U.S. in 2023. The rising technological advances in cancer diagnostic treatment methods and cancer therapies have spurred the number of new strategies such as partnership, merger and product launches. For instance, in April 2023, Bio-Techne announced a strategic partnership to develop the first fully automated spatial multiomics workflow with same-slide hyperplex detection of protein and RNA biomarkers. Designed to provide ultimate flexibility in panel design, the solution will allow researchers to easily combine well-characterized antibodies with gold-standard RNAscope in situ hybridization probes to illuminate changes in cell phenotypes and functional states across a wide range of diseases.
Further, increasing strategic initiatives by the key players and investing activities in another factor driving the growth of the market, for instance, in February 2023, BD announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity potentially accelerating time to discovery across a wide range of disciplines including immunology, genetic disease research, and cancer and chronic disease research. The BD Rhapsody HT Xpress System enables scientists to isolate, barcode and analyze single cells at a high sample throughput up to eight times more cells than prior versions of BD single-cell analyzers.
To Request a Sample of our Report on Single-cell omics Market: https://www.omrglobal.com/request-sample/single-cell-omics-market
Market Coverage
- The market number available for – 2023-2030
- Base year- 2022
- Forecast period- 2024-2030
Segment Covered-
- By Product Type
- By Application
- By End User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- includes, Becton, Dickinson and Company, Berkeley Lights Inc, BGI Genomics Co. Ltd, Danaher Corp, Dolomite Bio, Epicypher Inc., Fluidigm Corp, Illimina, Inc, Miltenyi Biotec B.V. & CO., and others.
Single-cell omics Market Report Segment
By Product Type:
- Single-Cell Genomics
- Single-Cell Transcriptomics
- Single-Cell Proteomics
- Single-Cell Metabolomics
By Application:
- Oncology
- Cell Biology
- Neurology
- Immunology
- other (Microbiology)
By End user:
- Pharma and biotech companies
- Academic and Research Organizations
- Hospital and Diagnostic Laboratories
A full report of Single-cell omics Market available @ https://www.omrglobal.com/industry-reports/single-cell-omics-market
Single-cell omics Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Becton, Dickinson and Company
- Berkeley Lights Inc
- BGI Genomics Co. Ltd
- Danaher Corp (Cytiva Life Sciences)
- Dolomite Bio
- Epicypher Inc.
- Fluidigm Corp
- Illimina, Inc
- Miltenyi Biotec B.V. & CO.
- Nanostring Technologies, Inc
- Olink Holding AB (Olink Proteomics)
- Parse Bioscience
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
